Matches in SemOpenAlex for { <https://semopenalex.org/work/W2605017029> ?p ?o ?g. }
- W2605017029 endingPage "917" @default.
- W2605017029 startingPage "903" @default.
- W2605017029 abstract "Objective Cancer stem cells (CSCs) are responsible for tumour formation and spreading, and their targeting is required for tumour eradication. There are limited therapeutic options for advanced colorectal cancer (CRC), particularly for tumours carrying RAS-activating mutations. The aim of this study was to identify novel CSC-targeting strategies. Design To discover potential therapeutics to be clinically investigated as single agent, we performed a screening with a panel of FDA-approved or investigational drugs on primary CRC cells enriched for CSCs (CRC-SCs) isolated from 27 patients. Candidate predictive biomarkers of efficacy were identified by integrating genomic, reverse-phase protein microarray (RPPA) and cytogenetic analyses, and validated by immunostainings. DNA replication stress (RS) was increased by employing DNA replication-perturbing or polyploidising agents. Results The drug-library screening led to the identification of LY2606368 as a potent anti-CSC agent acting in vitro and in vivo in tumour cells from a considerable number of patients (∼36%). By inhibiting checkpoint kinase (CHK)1, LY2606368 affected DNA replication in most CRC-SCs, including RAS-mutated ones, forcing them into premature, lethal mitoses. Parallel genomic, RPPA and cytogenetic analyses indicated that CRC-SCs sensitive to LY2606368 displayed signs of ongoing RS response, including the phosphorylation of RPA32 and ataxia telangiectasia mutated serine/threonine kinase (ATM). This was associated with mutation(s) in TP53 and hyperdiploidy, and made these CRC-SCs exquisitely dependent on CHK1 function. Accordingly, experimental increase of RS sensitised resistant CRC-SCs to LY2606368. Conclusions LY2606368 selectively eliminates replication-stressed, p53-deficient and hyperdiploid CRC-SCs independently of RAS mutational status. These results provide a strong rationale for biomarker-driven clinical trials with LY2606368 in patients with CRC." @default.
- W2605017029 created "2017-04-14" @default.
- W2605017029 creator A5001061030 @default.
- W2605017029 creator A5004436634 @default.
- W2605017029 creator A5017020400 @default.
- W2605017029 creator A5017380683 @default.
- W2605017029 creator A5017459750 @default.
- W2605017029 creator A5023710153 @default.
- W2605017029 creator A5029232262 @default.
- W2605017029 creator A5030335157 @default.
- W2605017029 creator A5031136109 @default.
- W2605017029 creator A5032469956 @default.
- W2605017029 creator A5034462695 @default.
- W2605017029 creator A5042097944 @default.
- W2605017029 creator A5042736335 @default.
- W2605017029 creator A5048934823 @default.
- W2605017029 creator A5056587668 @default.
- W2605017029 creator A5057548226 @default.
- W2605017029 creator A5063051267 @default.
- W2605017029 creator A5065356075 @default.
- W2605017029 creator A5065469646 @default.
- W2605017029 creator A5066153480 @default.
- W2605017029 creator A5066981430 @default.
- W2605017029 creator A5067317332 @default.
- W2605017029 creator A5067656240 @default.
- W2605017029 creator A5074096250 @default.
- W2605017029 creator A5075650555 @default.
- W2605017029 creator A5082149678 @default.
- W2605017029 date "2017-04-07" @default.
- W2605017029 modified "2023-09-29" @default.
- W2605017029 title "CHK1-targeted therapy to deplete DNA replication-stressed, p53-deficient, hyperdiploid colorectal cancer stem cells" @default.
- W2605017029 cites W1594035260 @default.
- W2605017029 cites W1741548448 @default.
- W2605017029 cites W1863134146 @default.
- W2605017029 cites W1968657935 @default.
- W2605017029 cites W1983567075 @default.
- W2605017029 cites W1984373702 @default.
- W2605017029 cites W1984984201 @default.
- W2605017029 cites W1987443121 @default.
- W2605017029 cites W1988758354 @default.
- W2605017029 cites W1998728654 @default.
- W2605017029 cites W1999402226 @default.
- W2605017029 cites W2004878973 @default.
- W2605017029 cites W2006168411 @default.
- W2605017029 cites W2007513598 @default.
- W2605017029 cites W2010873488 @default.
- W2605017029 cites W2011217149 @default.
- W2605017029 cites W2015061258 @default.
- W2605017029 cites W2016426158 @default.
- W2605017029 cites W2029231546 @default.
- W2605017029 cites W2040681936 @default.
- W2605017029 cites W2040860750 @default.
- W2605017029 cites W2060551076 @default.
- W2605017029 cites W2064980447 @default.
- W2605017029 cites W2065087624 @default.
- W2605017029 cites W2065434335 @default.
- W2605017029 cites W2067424975 @default.
- W2605017029 cites W2072544833 @default.
- W2605017029 cites W2072693879 @default.
- W2605017029 cites W2073483289 @default.
- W2605017029 cites W2082559623 @default.
- W2605017029 cites W2084833108 @default.
- W2605017029 cites W2089190410 @default.
- W2605017029 cites W2098736886 @default.
- W2605017029 cites W2102209369 @default.
- W2605017029 cites W2106391833 @default.
- W2605017029 cites W2112703519 @default.
- W2605017029 cites W2114860131 @default.
- W2605017029 cites W2120656656 @default.
- W2605017029 cites W2135523574 @default.
- W2605017029 cites W2142031018 @default.
- W2605017029 cites W2142125232 @default.
- W2605017029 cites W2145264022 @default.
- W2605017029 cites W2147297736 @default.
- W2605017029 cites W2157910818 @default.
- W2605017029 cites W2159512367 @default.
- W2605017029 cites W2262414037 @default.
- W2605017029 cites W2295718866 @default.
- W2605017029 cites W2301536592 @default.
- W2605017029 cites W2338722087 @default.
- W2605017029 cites W2419025306 @default.
- W2605017029 doi "https://doi.org/10.1136/gutjnl-2016-312623" @default.
- W2605017029 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/5890648" @default.
- W2605017029 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/28389531" @default.
- W2605017029 hasPublicationYear "2017" @default.
- W2605017029 type Work @default.
- W2605017029 sameAs 2605017029 @default.
- W2605017029 citedByCount "58" @default.
- W2605017029 countsByYear W26050170292017 @default.
- W2605017029 countsByYear W26050170292018 @default.
- W2605017029 countsByYear W26050170292019 @default.
- W2605017029 countsByYear W26050170292020 @default.
- W2605017029 countsByYear W26050170292021 @default.
- W2605017029 countsByYear W26050170292022 @default.
- W2605017029 countsByYear W26050170292023 @default.
- W2605017029 crossrefType "journal-article" @default.
- W2605017029 hasAuthorship W2605017029A5001061030 @default.
- W2605017029 hasAuthorship W2605017029A5004436634 @default.